CPhI report notes that the Indonesian pharma market is on the brink of a regional manufacturing boom, with market capitalizations and company values rising.
Adeline Siew, PhD
Advertisement
Adeline Siew is editor for Pharmaceutical Technology Europe. She is also science editor for Pharmaceutical Technology.
Articles by Adeline Siew, PhD
WHO says that results from clinical trials should be reported within 12 months of completion of the study
Generic drugs save patients and European healthcare systems approximately EUR 35 billion (US$46bn) each year, according to the European Generics Association (EGA).
Industry experts talk to Pharmaceutical Technology's Adeline Siew about the requirements and challenges involved in getting a biosimilar product to market.
The global market for biosimilar drugs has been forecasted to be worth $2.445 billion this year, according to a new report by British market research specialist Visiongain
Advertisement
Latest Updated Articles
Biosimilars: Challenges from Bench to LaunchPublished: October 3rd 2013 | Updated:
- From the Generic to the Supergeneric Era
Published: September 2nd 2014 | Updated:
- Global Biosimilars Market to Reach $2.4 Billion in 2013
Published: May 17th 2013 | Updated:
- WHO Pushes for Prompt Reporting and Public Disclosure of Clinical Trial Data
Published: April 17th 2015 | Updated:
- Indonesian Pharma Poised for Strong Growth
Published: April 22nd 2015 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Organon CEO Kevin Ali to Resign Following Internal Investigation into Nexplanon Sales
2
Study Claims Ozempic Lowers Biological Age
3
GSK Agrees to $357 Million Exclusive License Agreement for Syndivia’s AntiBody-Drug Conjugate
4
How will DTC Programs Impact PBMs?
5
